Clinical neurocardiology: defining the value of neuroscience‐based cardiovascular therapeutics – 2024 update
The Journal of Physiology · 2025-03 · 603 (7) · 1781-1839
DOI: 10.1113/jp284741 ↗At a glance
Übersichtsarbeit in The Journal of Physiology, published online on 2025-03-08. Written by Olujimi A Ajijola and 21 co-authors. Institution: UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of Excellence, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Major MEDLINE topics: Autonomic Nervous System, Cardiovascular Diseases, Heart. Cited 30 times so far (Crossref); 521 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS.
Abstract (original language)
The intricate role of the autonomic nervous system (ANS) in regulating cardiac physiology has long been recognized. Aberrant function of the ANS is central to the pathophysiology of cardiovascular diseases. It stands to reason, therefore, that neuroscience‐based cardiovascular therapeutics hold great promise in the treatment of cardiovascular diseases in humans. A decade after the inaugural edition, this White Paper reviews the current state of understanding of human cardiac neuroanatomy, neurophysiology and pathophysiology in specific disease conditions, autonomic testing, risk stratification, and neuromodulatory strategies to mitigate the progression of cardiovascular diseases. image
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of Excellence, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
- Division of Cardiology, Yeditepe University Hospital, Istanbul, Türkiye.
- Division of Cardiology, Northwestern Feinberg School of Medicine, Chicago, IL, USA.
- Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Cardiology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
- Department of Medical Sciences, University of Turin, Italy and Division of Cardiology, Cardiovascular and Thoracic Department, 'Città della Salute e della Scienza' Hospital, Torino, Italy.
Funding
- NHLBI NIH HHS
Cite
APA
Ajijola, O. A., Aksu, T., Arora, R., Biaggioni, I., Chen, P. S., De Ferrari, G., Dusi, V., Fudim, M., Goldberger, J. J., Green, A. L., Herring, N., Khalsa, S. S., Kumar, R., Lakatta, E., Mehra, R., Meyer, C., Po, S., Stavrakis, S., Somers, V. K., …, & Shivkumar, K. (2025). Clinical neurocardiology: defining the value of neuroscience‐based cardiovascular therapeutics – 2024 update. The Journal of Physiology, 603(7), 1781-1839. https://doi.org/10.1113/jp284741
Vancouver
Ajijola OA, Aksu T, Arora R, Biaggioni I, Chen PS, De Ferrari G, et al. Clinical neurocardiology: defining the value of neuroscience‐based cardiovascular therapeutics – 2024 update. The Journal of Physiology. 2025;603(7):1781-1839. doi:10.1113/jp284741
BibTeX
@article{Ajijola2025,
author = {Ajijola, Olujimi A and Aksu, Tolga and Arora, Rishi and Biaggioni, Italo and Chen, Peng-Sheng and De Ferrari, Gaetano and Dusi, Veronica and Fudim, Marat and Goldberger, Jeffrey J and Green, Alexander L and Herring, Neil and Khalsa, Sahib S and Kumar, Rajesh and Lakatta, Edward and Mehra, Reena and Meyer, Christian and Po, Sunny and Stavrakis, Stavros and Somers, Virend K and Tan, Alex Y and Valderrabano, Miguel and Shivkumar, Kalyanam},
title = {Clinical neurocardiology: defining the value of neuroscience‐based cardiovascular therapeutics – 2024 update},
journal = {The Journal of Physiology},
year = {2025},
volume = {603},
number = {7},
pages = {1781--1839},
doi = {10.1113/jp284741}
}
EUVIMED